Flattened 3D Cell Cultures for Standardized Neural Activity Measurement

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing in vitro models for studying pain and opioid interactions lack the integration of electrical measuring methods with good throughput and standardization, particularly in spinal cord organoid cultures, which are crucial for understanding pain circuitry and opioid responses.

Innovation Solution

A 3D printed microfluidic device with a gas permeable membrane is used to restrict organoid growth to less than 1000 micrometers in thickness, allowing for the growth of flattened spinal cord organoids that facilitate electrophysiology measurements and longitudinal monitoring of neural activity, including the use of capsaicin and DAMGO to model pain responses.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Shape

If conventional 3D organoid cultures are used, then organoid complexity and self-organization are achieved, but thickness exceeds 1000 micrometers leading to heterogeneity and hypoxia

Engineering Contradiction:
Improveorganoid thicknessVSAvoidorganoid homogeneity
Core Design Contradiction:
ShapeVSReliability

Solution Approach 1:

The invention transitions from conventional spherical 3D organoid geometry to a flattened 2D-like configuration by constraining growth between parallel plates. This dimensional change reduces thickness to under 1000 micrometers while maintaining 3D cellular organization, thereby eliminating hypoxia and heterogeneity without sacrificing organoid complexity.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The invention changes the physical constraint parameter from unconstrained spherical growth to bounded growth between parallel plates spaced 1-1000 micrometers apart. This parameter change forces the organoid to adopt a flattened morphology with controlled thickness, ensuring uniform oxygen and nutrient distribution throughout the culture.

Inventive Principle:
Principle #35Parameter changes

2Difficulty of detecting and measuring

If conventional organoid cultures are used, then tissue complexity is maintained, but electrical measuring integration is insufficient

Engineering Contradiction:
Improveelectrical activity measurementVSAvoidmeasurement system integration
Core Design Contradiction:
Difficulty of detecting and measuringVSDevice complexity

Solution Approach 1:

The invention merges the organoid culture system with electrophysiological measurement capabilities by integrating microelectrode arrays directly into the flattened organoid structure. This combination enables simultaneous cultivation and electrical activity recording, eliminating the need for separate measurement systems and facilitating longitudinal studies of neural function.

Inventive Principle:
Principle #5Merging (Combining)

3Stability of the object's composition

If thick 3D organoid cultures are used, then self-organization is achieved, but hypoxia and necrosis occur

Engineering Contradiction:
Improveorganoid self-organizationVSAvoidhypoxia and necrosis
Core Design Contradiction:
Stability of the object's compositionVSObject-affected harmful factors

Solution Approach 1:

By changing the spatial configuration from thick 3D spherical structures to flattened thin-profile organoids, the invention maintains cellular self-organization while reducing diffusion distances for oxygen and nutrients. This dimensional transformation prevents hypoxia and necrosis in the core regions that plague conventional thick organoid cultures.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method enables the fabrication of human spinal cord organoids with abundant neural activity, reducing heterogeneity and hypoxia, and allows for repeatable sampling and monitoring of electrical activity, effectively modeling opioid-induced hyperalgesia and tolerance.

Implementation Method 1

a gas permeable membrane for fabricating flattened spinal cord organoids

Methodology Applied
Scientific EffectGas permeation: Permeation

Data Source

PatentUS20250290032A1Device and methods for engineering and measuring flattened 3D cell cultures
Publication Date: 2025.09.18 THE TRUSTEES OF INDIANA UNIV
  • US20250290032A1 patent drawing
  • US20250290032A1 patent drawing
  • US20250290032A1 patent drawing

AI summary

The invention relates to improved methods for growing and measuring flattened 3D cell cultures, to the 3D printed scaffolds involved in said methods, and to uses of said 3D cell cultures.